Refocussing Antibody Responses by Chemical Modification of Vaccine Antigens

AIDS Research and Human RetrovirusesVol. 30, No. S1 Adjuvants and ImmunogensRefocussing Antibody Responses by Chemical Modification of Vaccine AntigensTorben Schiffner, Karolis Leonavicius, Heiko Schuster, Helen J. Kim, Leopold Kong, Regis Saliba, Florian Brod, Frank Wegmann, Po-Ssu Huang, Guillaume B. Stewart-Jones, William R. Schief, Andrew B. Ward, John P. Moore, Rogier W. Sanders, Benjamin G. Davis, and Quentin J. SattentauTorben SchiffnerUniversity of Oxford, Sir William Dunn School of Pathology, Oxford, United KingdomSearch for more papers by this author, Karolis LeonaviciusUniversity of Oxford, Department of Chemistry, Oxford, United KingdomSearch for more papers by this author, Heiko SchusterUniversity of Oxford, Department of Chemistry, Oxford, United KingdomSearch for more papers by this author, Helen J. KimIAVI Neutralizing Antibody Center at The Scripps Research Institute, San Diego, CA, United StatesSearch for more papers by this author, Leopold KongUniversity of Oxford, Sir William Dunn School of Pathology, Oxford, United KingdomIAVI Neutralizing Antibody Center at The Scripps Research Institute, San Diego, CA, United StatesSearch for more papers by this author, Regis SalibaUniversity of Oxford, Department of Chemistry, Oxford, United KingdomSearch for more papers by this author, Florian BrodUniversity of Oxford, Sir William Dunn School of Pathology, Oxford, United KingdomSearch for more papers by this author, Frank WegmannUniversity of Oxford, Sir William Dunn School of Pathology, Oxford, United KingdomSearch for more papers by this author, Po-Ssu HuangUniversity of Washington, Washington, WA, United StatesSearch for more papers by this author, Guillaume B. Stewart-JonesUniversity of Oxford, The Weatherall Institute of Molecular Medicine, Oxford, United KingdomSearch for more papers by this author, William R. SchiefIAVI Neutralizing Antibody Center at The Scripps Research Institute, San Diego, CA, United StatesUniversity of Washington, Washington, WA, United StatesRagon Institute of MGH, MIT and Harvard, Cambridge, MA, United StatesSearch for more papers by this author, Andrew B. WardIAVI Neutralizing Antibody Center at The Scripps Research Institute, San Diego, CA, United StatesSearch for more papers by this author, John P. MooreWeill Cornell Medical College, New York, NY, United StatesSearch for more papers by this author, Rogier W. SandersWeill Cornell Medical College, New York, NY, United StatesUniversity of Amsterdam, Amsterdam, NetherlandsSearch for more papers by this author, Benjamin G. DavisUniversity of Oxford, Department of Chemistry, Oxford, United KingdomSearch for more papers by this author, and Quentin J. SattentauUniversity of Oxford, Sir William Dunn School of Pathology, Oxford, United KingdomSearch for more papers by this authorPublished Online:30 Oct 2014https://doi.org/10.1089/aid.2014.5121.abstractAboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Refocussing Antibody Responses by Chemical Modification of Vaccine Antigens." AIDS Research and Human Retroviruses, 30(S1), pp. A66–A67FiguresReferencesRelatedDetails Volume 30Issue S1Oct 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Torben Schiffner, Karolis Leonavicius, Heiko Schuster, Helen J. Kim, Leopold Kong, Regis Saliba, Florian Brod, Frank Wegmann, Po-Ssu Huang, Guillaume B. Stewart-Jones, William R. Schief, Andrew B. Ward, John P. Moore, Rogier W. Sanders, Benjamin G. Davis, and Quentin J. Sattentau.Refocussing Antibody Responses by Chemical Modification of Vaccine Antigens.AIDS Research and Human Retroviruses.Oct 2014.A66-A67.http://doi.org/10.1089/aid.2014.5121.abstractPublished in Volume: 30 Issue S1: October 30, 2014PDF download